CSIMarket
 


Supernus Pharmaceuticals inc   (SUPN)
Other Ticker:  
 

Supernus Pharmaceuticals Inc 's Total Debt to Equity

SUPN's quarterly Total Debt to Equity and Total Debt, Equity growth


In the third quarter 2023 Supernus Pharmaceuticals Inc did not have Total Debt.

Within Major Pharmaceutical Preparations industry Supernus Pharmaceuticals inc achieved the lowest Total Debt to Equity in the third quarter 2023. While total ranking remained the same in the third quarter 2023 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of SUPN´s Total Debt?
How valuable is the SUPN´s Equity?


SUPN Total Debt to Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 6.96 % 9.33 % 10.1 % 8.62 % 5.22 %
Y / Y Total Debt Change - - 0.53 % 5.99 % 7.11 %
Total Debt to Equity MRQ - - 0.44 0.45 0.47
SUPN's Total Ranking # # # # #
Seq. Equity Change -0.84 % 0.85 % 2.93 % 3.92 % 1.35 %
Seq. Total Debt Change - - 0.13 % 0.13 % 0.13 %



Total Debt to Equity third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Supernus Pharmaceuticals Inc 's Equity $ 912 Millions Visit SUPN's Balance sheet
Supernus Pharmaceuticals Inc 's Total Debt $ 0 Millions Visit SUPN's Balance sheet
Source of SUPN's Sales Visit SUPN's Sales by Geography


Cumulative Supernus Pharmaceuticals Inc 's Total Debt to Equity

SUPN's Total Debt to Equity for the trailling 12 Months

SUPN Total Debt to Equity

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth 6.96 % 9.33 % 10.1 % 8.62 % 5.22 %
Y / Y Total Debt TTM Growth - - 0.53 % 5.99 % 7.11 %
Total Debt to Equity TTM 0.22 0.34 0.46 0.47 0.47
Total Ranking TTM
Seq. Equity TTM Growth -0.84 % 0.85 % 2.93 % 3.92 % 1.35 %
Seq. Total Debt TTM Growth - - 0.13 % 0.13 % 0.13 %


On the trailing twelve months basis During the twelve months ending III Quarter 2023 Supernus Pharmaceuticals Inc did not have Total Debt .
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 4, during the past 12 months, other companies have achieved lower Total Debt to Equity than Supernus Pharmaceuticals Inc . While total ranking remained unchanged compared to previous 12 month period at no. 54.

Explain Debt to Equity Ratio?
What is the structure of SUPN´s Total Debt?
How valuable is the SUPN´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 17
Within the Market #


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.8 0.49 0.05
(Dec 31 2018)   (Dec 31 2017)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquitySep 30 2023 MRQ Total DebtSep 30 2023 MRQ Equity

Date modified: 2023-11-09T22:44:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com